MRI of nonischemic cardiomyopathy.

OBJECTIVE The purpose of this article is to present current clinical and research issues in MRI evaluation of nonischemic cardiomyopathy, a diverse set of diseases, many of which have a genetic basis. CONCLUSION Cardiac cine MRI along with delayed myocardial enhancement MRI and other MRI techniques can provide information beyond echocardiography for tissue characterization. MRI is increasingly being used for evaluation of genetically positive, phenotypically negative patients as well as for risk stratification.

[1]  W. Manning,et al.  Hypertrophic cardiomyopathy phenotype revisited after 50 years with cardiovascular magnetic resonance. , 2009, Journal of the American College of Cardiology.

[2]  Hugh Calkins,et al.  Axial black blood turbo spin echo imaging of the right ventricle , 2009, Magnetic resonance in medicine.

[3]  B. Maron,et al.  Hypertrophic cardiomyopathy without hypertrophy: an emerging pre-clinical subgroup composed of genetically affected family members. , 2009, JACC. Cardiovascular imaging.

[4]  H. Calkins,et al.  Role of cardiovascular magnetic resonance imaging in arrhythmogenic right ventricular dysplasia , 2008, Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance.

[5]  C. Higgins,et al.  MRI in nonischemic acquired heart disease , 2008, Journal of magnetic resonance imaging : JMRI.

[6]  J. Glockner,et al.  Cardiac MR imaging of nonischemic cardiomyopathies. , 2008, Magnetic resonance imaging clinics of North America.

[7]  S. Dymarkowski,et al.  The role of cardiovascular magnetic resonance in the diagnosis and management of cardiomyopathies. , 2008, Journal of cardiovascular medicine.

[8]  J. Lima,et al.  Cardiovascular magnetic resonance for risk stratification of arrhythmia in hypertrophic cardiomyopathy. , 2008, Journal of the American College of Cardiology.

[9]  W. Manning,et al.  Occurrence and frequency of arrhythmias in hypertrophic cardiomyopathy in relation to delayed enhancement on cardiovascular magnetic resonance. , 2008, Journal of the American College of Cardiology.

[10]  Evrim B Turkbey,et al.  Role of Cardiac Magnetic Resonance Imaging in Assessment of Nonischemic Cardiomyopathies , 2008, Topics in magnetic resonance imaging : TMRI.

[11]  James A. White,et al.  The role of cardiovascular MRI in heart failure and the cardiomyopathies. , 2007, Magnetic resonance imaging clinics of North America.

[12]  D. Bluemke,et al.  MRI to Assess Arrhythmia and Cardiomyopathies: Relationship to Echocardiography , 2007, Echocardiography.

[13]  H. Calkins,et al.  Magnetic resonance imaging of arrhythmogenic right ventricular dysplasia: sensitivity, specificity, and observer variability of fat detection versus functional analysis of the right ventricle. , 2006, Journal of the American College of Cardiology.

[14]  Barry J Maron,et al.  Contemporary definitions and classification of the cardiomyopathies: an American Heart Association Scientific Statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interd , 2006, Circulation.

[15]  C. Rochitte,et al.  The emerging role of MRI in the diagnosis and management of cardiomyopathies , 2006, Current cardiology reports.

[16]  C. Kramer,et al.  The evolving role of cardiovascular magnetic resonance imaging in nonischemic cardiomyopathy. , 2006, Seminars in ultrasound, CT, and MR.

[17]  Michael Jerosch-Herold,et al.  Utility of Cardiac Magnetic Resonance Imaging in the Diagnosis of Hypertrophic Cardiomyopathy , 2005, Circulation.

[18]  Peter Hunold,et al.  Myocardial late enhancement in contrast-enhanced cardiac MRI: distinction between infarction scar and non-infarction-related disease. , 2005, AJR. American journal of roentgenology.

[19]  P. Spector.  Diagnosis and management of sudden cardiac death , 2005, Heart.

[20]  H. Calkins,et al.  Arrhythmogenic right ventricular dysplasia: ex vivo and in vivo fat detection with black-blood MR imaging. , 2004, Radiology.

[21]  H. Calkins,et al.  Magnetic resonance and computed tomography imaging of arrhythmogenic right ventricular dysplasia , 2004, Journal of magnetic resonance imaging : JMRI.

[22]  Edward Kasper,et al.  Misdiagnosis of Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy , 2004, Journal of cardiovascular electrophysiology.

[23]  H. Calkins,et al.  Journal of Cardiovascular Magnetic Resonance Mri of Arrhythmogenic Right Ventricular Cardiomyopathy/dysplasia , 2022 .

[24]  B. Sievers,et al.  Journal of Cardiovascular Magnetic Resonance Right Ventricular Wall Motion Abnormalities Found in Healthy Subjects by Cardiovascular Magnetic Resonance Imaging and Characterized with a New Segmental Model , 2022 .

[25]  S. Solomon,et al.  Assessment of Diastolic Function With Doppler Tissue Imaging to Predict Genotype in Preclinical Hypertrophic Cardiomyopathy , 2002, Circulation.

[26]  A. Nava,et al.  Diagnosis of arrhythmogenic right ventricular dysplasia/cardiomyopathy. Task Force of the Working Group Myocardial and Pericardial Disease of the European Society of Cardiology and of the Scientific Council on Cardiomyopathies of the International Society and Federation of Cardiology. , 1994, British heart journal.